Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
Clinical trial NCT02429505 · WITHDRAWN
Trial details
- NCT number
- NCT02429505
- Sponsor
- Knight Therapeutics (USA) Inc
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2015-07-01
- Primary completion
- 2020-03-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.